Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
ResMed Inc. Initiates $450 Million Accelerated Share Repurchase
PUBLIC · RMDAug 31, 2026•8 days ago
Amount Raised
$450 Million
Round Type
Funding Round
United StatesMobileHealth CareSportsMedical Device
Investors
Citibank
Description
On August 31, 2026, ResMed Inc. entered into an accelerated share repurchase agreement with Citibank to repurchase $450 million of its common stock. The funding for this repurchase is intended to be sourced from the sale of its MatrixCare business and existing cash reserves. This agreement follows a repurchase authorization for a total of 20 million shares approved by the board of directors in February 2014.
Company Information
Company
ResMed
Location
United States
About
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
Don't miss ResMed's next move
Get an email the moment ResMed raises, hires an exec, or expands, usually minutes after it happens.
United StatesMobileHealth CareSportsMedical Device